Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
SBIO
84
HOLDINGS
17%
ALSO IN XPH
XPH
57
HOLDINGS
24%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
VERADERMICS INC | 3.9% | 2.8% | 2.8% |
|
DEFINIUM THERAPEUTICS INC | 3.2% | 1.9% | 1.9% |
|
TARSUS PHARMACEUTICALS, INC. | 2.2% | 1.8% | 1.8% |
|
EDGEWISE THERAPEUTICS, INC. | 2.8% | 1.8% | 1.8% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.4% | 1.8% | 1.8% |
SBIO Overweight Relative to XPH
|
ORUKA THERAPEUTICS INC | 4.3% |
|
CG ONCOLOGY, INC. | 3.8% |
|
TRAVERE THERAPEUTICS, INC. | 3.2% |
|
DIANTHUS THERAPEUTICS INC | 3.1% |
|
RELAY THERAPEUTICS, INC. | 2.7% |
|
ACADIA PHARMACEUTICALS INC | 2.4% |
|
DYNE THERAPEUTICS INC | 2.1% |
|
DISC MEDICINE, INC. | 2.1% |
|
IDEAYA BIOSCIENCES, INC. | 2.1% |
|
DENALI THERAPEUTICS INC. | 2.0% |
SBIO Underweight Relative to XPH
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
ELI LILLY & CO | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.5% |
|
VIATRIS, INC. | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
 |
PERRIGO CO | -2.2% |
|
PFIZER INC | -2.2% |
|
ZOETIS INC | -2.2% |
|
SEPTERNA INC | -2.2% |